Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Eculizumab

EU orphan designation number: EU/3/12/1015   
Active ingredient: Eculizumab
Indication: Treatment of infection-associated haemolytic uraemic syndrome
Sponsor: Alexion Europe SAS
25 boulevard de l'Amiral Bruix, F-75016 Paris, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/07/2012 Centralised Orphan - Designation EMA/OD/013/12 (2012)4769 of 04/07/2012